Patents by Inventor Petra Dörfler

Petra Dörfler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rucaparib, Talazoparib, Veliparib, Olaparib and AZD 2461 for treating impaired skin wound healing
    Patent number: 11638709
    Abstract: The present invention relates to Rucaparib and/or Talazoparib and/or Veliparib and/or Olaparib, and/or AZD 2461, or a pharmaceutically acceptable salt thereof, for use in the treatment of impaired skin wound healing in a subject, an in vitro method for identifying a subject suffering from impaired skin wound healing to be responsive to the treatment with Rucaparib and/or Talazoparib and/or Veliparib and/or Olaparib and/or AZD 2461, and kits and kits-of-part related thereto.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: May 2, 2023
    Assignee: AKRIBES BIOMEDICAL GMBH
    Inventors: Barbara Wolff-Winiski, Anton Stütz, Petra Dörfler
  • Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
    Patent number: 11579141
    Abstract: The present invention relates to an in vitro method for identifying a skin wound in an individual as being a non-healing skin wound or healing skin wound, in vitro methods for monitoring the healing of a skin wound in an individual, methods for screening for compounds suitable for modulating skin wound healing, as well as kits related thereto.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: February 14, 2023
    Assignee: AKRIBES BIOMEDICAL GMBH
    Inventors: Barbara Wolff-Winiski, Anton Stütz, Petra Dörfler
  • SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
    Publication number: 20220047602
    Abstract: The present invention relates to a Selective Glucocorticoid Receptor Modulator (SEGRM), or a pharmaceutically acceptable salt thereof, for use in the treatment of impaired skin wound healing in a subject, an in vitro method for identifying a subject suffering from impaired skin wound healing to be responsive to the treatment with a Selective Glucocorticoid Receptor Modulator (SEGRM), or a pharmaceutically acceptable salt thereof, and kits and kits-of-part related thereto.
    Type: Application
    Filed: July 20, 2021
    Publication date: February 17, 2022
    Applicant: AKRIBES BIOMEDICAL GMBH
    Inventors: Barbara WOLFF-WINISKI, Anton STÜTZ, Nicole SCHÖFMANN, Petra DÖRFLER
  • PARP Inhibitor in Combination with a Glucocorticoid and/or Ascorbic Acid and/or a Protein Growth Factor for the Treatment of Impaired Wound Healing
    Publication number: 20200129476
    Abstract: The present invention relates to a PARP inhibitor in combination with a glucocorticoid and/or ascorbic acid and/or a protein growth factor for the treatment of impaired wound healing.
    Type: Application
    Filed: April 24, 2018
    Publication date: April 30, 2020
    Applicant: AKRIBES BIOMEDICAL GMBH
    Inventors: BARBARA WOLFF-WINISKI, ANTON STÜTZ, PETRA DÖRFLER
  • Rucaparib, Talazoparib, Veliparib, Olaparib and AZD 2461 for Treating Impaired Skin Wound Healing
    Publication number: 20200078369
    Abstract: The present invention relates to Rucaparib and/or Talazoparib and/or Veliparib and/or Olaparib, and/or AZD 2461, or a pharmaceutically acceptable salt thereof, for use in the treatment of impaired skin wound healing in a subject, an in vitro method for identifying a subject suffering from impaired skin wound healing to be responsive to the treatment with Rucaparib and/or Talazoparib and/or Veliparib and/or Olaparib and/or AZD 2461, and kits and kits-of-part related thereto.
    Type: Application
    Filed: April 24, 2018
    Publication date: March 12, 2020
    Applicant: AKRIBES BIOMEDICAL GMBH
    Inventors: BARBARA WOLFF-WINISKI, ANTON STÜTZ, PETRA DÖRFLER
  • METHODS FOR IDENTIFYING A NON-HEALING SKIN WOUND AND FOR MONITORING THE HEALING OF A SKIN WOUND
    Publication number: 20200025746
    Abstract: The present invention relates to an in vitro method for identifying a skin wound in an individual as being a non-healing skin wound or healing skin wound, in vitro methods for monitoring the healing of a skin wound in an individual, methods for screening for compounds suitable for modulating skin wound healing, as well as kits related thereto.
    Type: Application
    Filed: October 23, 2017
    Publication date: January 23, 2020
    Inventors: Barbara Wolff-Winiski, Anton Stütz, Petra Dörfler